Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges
2024

Helicobacter pylori Eradication and Gastric Cancer Prevention

Sample size: 180284 publication 10 minutes Evidence: high

Author Information

Author(s): Liu Zongchao, Xu Hengmin, You Weicheng, Pan Kaifeng, Li Wenqing

Primary Institution: Peking University Cancer Hospital & Institute, Beijing, China

Hypothesis

Can Helicobacter pylori eradication effectively prevent gastric cancer?

Conclusion

Eradicating Helicobacter pylori significantly reduces the incidence and mortality of gastric cancer.

Supporting Evidence

  • H. pylori eradication has been shown to reduce gastric cancer incidence and mortality.
  • Long-term follow-up studies confirm the effectiveness of H. pylori treatment in preventing gastric cancer.
  • Community-based interventions have demonstrated significant benefits in high-risk populations.

Takeaway

Getting rid of Helicobacter pylori can help stop stomach cancer from happening.

Methodology

The study involved a large community-based trial with over 180,000 participants in Linqu County, China, assessing the effects of H. pylori treatment on gastric cancer prevention.

Potential Biases

Potential biases may arise from participant selection and adherence to treatment protocols.

Limitations

The study's findings may not be generalizable to populations outside of high-risk areas for gastric cancer.

Participant Demographics

Participants were aged 25-54 years from high-risk areas in Linqu County, Shandong Province, China.

Statistical Information

P-Value

0.86

Confidence Interval

0.74–0.99

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.jncc.2024.06.006

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication